NCT00647647View on ClinicalTrials.gov

Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Healthy
Interventions
DRUG

Terbinafine Hydrochloride Tablets 250 mg

250mg, single dose fasting

DRUG

Lamisil® Tablets 250 mg

250mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00647647 - Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mg | Biotech Hunter | Biotech Hunter